EP2111400A4 - Pyridine compounds and their use as p2y12 antagonists. - Google Patents

Pyridine compounds and their use as p2y12 antagonists.

Info

Publication number: EP2111400A4
Authority: EP; European Patent Office
Prior art keywords: antagonists; pyridine compounds; pyridine; compounds
Prior art date: 2007-01-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP08705190A

Other languages

German (de)

French (fr)

Other versions

EP2111400A1 (en

Inventor

Thomas Antonsson

Peter Bach

David Brown

Ruth Bylund

Fabrizio Giordanetto

Johan Johansson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

AstraZeneca AB

Original Assignee

AstraZeneca AB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-01-12

Filing date

2008-01-11

Publication date

2010-07-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39608896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP2111400(A4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-01-11 Application filed by AstraZeneca AB filed Critical AstraZeneca AB

2009-10-28 Publication of EP2111400A1 publication Critical patent/EP2111400A1/en

2010-07-07 Publication of EP2111400A4 publication Critical patent/EP2111400A4/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Hematology (AREA)
Transplantation (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

EP08705190A 2007-01-12 2008-01-11 Pyridine compounds and their use as p2y12 antagonists. Withdrawn EP2111400A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US88465807P	2007-01-12	2007-01-12
PCT/SE2008/000017 WO2008085117A1 (en)	2007-01-12	2008-01-11	Pyridine compounds and their use as p2y12 antagonists.

Publications (2)

Publication Number	Publication Date
EP2111400A1 EP2111400A1 (en)	2009-10-28
EP2111400A4 true EP2111400A4 (en)	2010-07-07

Family

ID=39608896

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP08705190A Withdrawn EP2111400A4 (en)	2007-01-12	2008-01-11	Pyridine compounds and their use as p2y12 antagonists.

Country Status (18)

Country	Link
US (2)	US20100137277A1 (en)
EP (1)	EP2111400A4 (en)
JP (1)	JP2010515728A (en)
KR (1)	KR20090096742A (en)
AR (1)	AR064866A1 (en)
AU (1)	AU2008203953A1 (en)
BR (1)	BRPI0806529A2 (en)
CA (1)	CA2674998A1 (en)
CL (1)	CL2008000091A1 (en)
CO (1)	CO6190618A2 (en)
EC (1)	ECSP099481A (en)
IL (1)	IL199439A0 (en)
MX (1)	MX2009007429A (en)
PE (1)	PE20081633A1 (en)
RU (1)	RU2009123928A (en)
TW (1)	TW200833335A (en)
UY (1)	UY30866A1 (en)
WO (1)	WO2008085117A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101506193A (en) *	2006-07-04	2009-08-12	阿斯利康(瑞典)有限公司	New pyridine analogues
WO2010005384A1 (en) *	2008-07-07	2010-01-14	Astrazeneca Ab	Ketone pyridine analogues and their use in the treatment of cardiovascular disorders
JP2014051434A (en) *	2010-12-28	2014-03-20	Dainippon Sumitomo Pharma Co Ltd	Bicyclic pyrimidine derivative
EP2750676B1 (en)	2011-08-30	2018-01-10	University of Utah Research Foundation	Methods and compositions for treating nephrogenic diabetes insipidus
RU2602456C1 (en) *	2015-10-20	2016-11-20	Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт акушерства, гинекологии и репродуктологии имени Д.О. Отта"	Method of assessing of aromatase activity of ovarian follicles
WO2017153235A1 (en)	2016-03-09	2017-09-14	Bayer Pharma Aktiengesellschaft	Substituted n-cyclo-3-aryl-1-naphthamides and use thereof
PE20190206A1 (en)	2016-07-19	2019-02-07	Bayer Cropscience Ag	DERIVATIVES OF BICYCLE HETEROCYCLES CONDENSED AS PESTICIDE
TW202415651A (en)	2022-07-29	2024-04-16	日商住友製藥股份有限公司	Nitrogen-containing saturated heterocyclyl derivative

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6156758A (en) *	1999-09-08	2000-12-05	Isis Pharmaceuticals, Inc.	Antibacterial quinazoline compounds
DK1257550T3 (en) *	2000-02-04	2006-03-27	Portola Pharm Inc	The platelet ADP receptor inhibitor
US6906063B2 (en) *	2000-02-04	2005-06-14	Portola Pharmaceuticals, Inc.	Platelet ADP receptor inhibitors
US7018985B1 (en) *	2000-08-21	2006-03-28	Inspire Pharmaceuticals, Inc.	Composition and method for inhibiting platelet aggregation
US7452870B2 (en) *	2000-08-21	2008-11-18	Inspire Pharmaceuticals, Inc.	Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7132408B2 (en) *	2000-08-21	2006-11-07	Inspire Pharmaceuticals, Inc.	Composition and method for inhibiting platelet aggregation
JP3500429B2 (en) *	2000-11-01	2004-02-23	現代自動車株式会社	Polypropylene resin composition
FR2820057A1 (en) *	2001-01-30	2002-08-02	Ct De Transfert De Technologie	MEMBRANE FOR ENCAPSULATING CHAMBER OF CELLS PRODUCING AT LEAST ONE BIOLOGICALLY ACTIVE SUBSTANCE AND BIO-ARTIFICIAL ORGAN COMPRISING SUCH A MEMBRANE
US7335648B2 (en) *	2003-10-21	2008-02-26	Inspire Pharmaceuticals, Inc.	Non-nucleotide composition and method for inhibiting platelet aggregation
US7749981B2 (en) *	2003-10-21	2010-07-06	Inspire Pharmaceuticals, Inc.	Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
US7504497B2 (en) *	2003-10-21	2009-03-17	Inspire Pharmaceuticals, Inc.	Orally bioavailable compounds and methods for inhibiting platelet aggregation
KR20070032648A (en) *	2004-05-12	2007-03-22	브리스톨-마이어스 스큅 컴퍼니	Urea antagonist of P281 receptor useful for the treatment of thrombosis
JP2008504275A (en) *	2004-06-24	2008-02-14	インサイト・コーポレイション	N-substituted piperidines and their use as pharmaceuticals
MX2007003870A (en) *	2004-10-04	2007-10-02	Wayne State Unviersity	Use of aromatase inhibitors for endometrial thinning in preparation for surgical procedures on the endometrial cavity and uterus.
BRPI0606437A (en) *	2005-01-06	2008-03-11	Astrazeneca Ab	compound or a pharmaceutically acceptable salt thereof, pharmaceutical composition, use of a compound, and method of treating a platelet aggregation disorder
EP1904474A4 (en) *	2005-07-13	2010-06-16	Astrazeneca Ab	New pyridine analogues
US20080045494A1 (en) *	2006-07-04	2008-02-21	Astrazeneca Ab	Pyridine Analogues VI
CN101506193A (en) *	2006-07-04	2009-08-12	阿斯利康(瑞典)有限公司	New pyridine analogues
BRPI0713957A2 (en) *	2006-07-04	2013-04-02	Astrazeneca Ab	compound, pharmaceutical composition, use of a compound, and method of treating a platelet aggregation disorder

2008
- 2008-01-11 AU AU2008203953A patent/AU2008203953A1/en not_active Abandoned
- 2008-01-11 UY UY30866A patent/UY30866A1/en unknown
- 2008-01-11 JP JP2009545521A patent/JP2010515728A/en active Pending
- 2008-01-11 RU RU2009123928/04A patent/RU2009123928A/en not_active Application Discontinuation
- 2008-01-11 AR ARP080100131A patent/AR064866A1/en unknown
- 2008-01-11 CA CA002674998A patent/CA2674998A1/en not_active Abandoned
- 2008-01-11 TW TW097101297A patent/TW200833335A/en unknown
- 2008-01-11 PE PE2008000130A patent/PE20081633A1/en not_active Application Discontinuation
- 2008-01-11 US US12/522,724 patent/US20100137277A1/en not_active Abandoned
- 2008-01-11 WO PCT/SE2008/000017 patent/WO2008085117A1/en active Application Filing
- 2008-01-11 US US11/972,831 patent/US20080171732A1/en not_active Abandoned
- 2008-01-11 CL CL200800091A patent/CL2008000091A1/en unknown
- 2008-01-11 EP EP08705190A patent/EP2111400A4/en not_active Withdrawn
- 2008-01-11 MX MX2009007429A patent/MX2009007429A/en not_active Application Discontinuation
- 2008-01-11 KR KR1020097015870A patent/KR20090096742A/en not_active Withdrawn
- 2008-01-11 BR BRPI0806529-2A2A patent/BRPI0806529A2/en not_active IP Right Cessation
2009
- 2009-06-18 IL IL199439A patent/IL199439A0/en unknown
- 2009-07-02 EC EC2009009481A patent/ECSP099481A/en unknown
- 2009-07-13 CO CO09072491A patent/CO6190618A2/en not_active Application Discontinuation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number	Publication date
US20080171732A1 (en)	2008-07-17
UY30866A1 (en)	2008-09-02
AU2008203953A1 (en)	2008-07-17
ECSP099481A (en)	2009-08-28
TW200833335A (en)	2008-08-16
MX2009007429A (en)	2009-07-17
AR064866A1 (en)	2009-04-29
KR20090096742A (en)	2009-09-14
WO2008085117A1 (en)	2008-07-17
IL199439A0 (en)	2010-03-28
CL2008000091A1 (en)	2008-09-05
PE20081633A1 (en)	2009-01-18
RU2009123928A (en)	2011-02-20
CA2674998A1 (en)	2008-07-17
JP2010515728A (en)	2010-05-13
BRPI0806529A2 (en)	2014-04-22
EP2111400A1 (en)	2009-10-28
CO6190618A2 (en)	2010-08-19
US20100137277A1 (en)	2010-06-03

Publication	Publication Date	Title
IL201620A0 (en)	2010-05-31	Quinoline-carboxamide derivatives as p2y12 antagonists
IL211892A0 (en)	2011-06-30	Pyrazolo pyridine derivatives, compositions comprising the same and uses thereof
IL214961A0 (en)	2011-11-30	Pyridine derivative compounds, compositions comprising the same and uses thereof
IL211890A0 (en)	2011-06-30	Pyrazolo pyridine derivatives, compositions comprising the same and uses thereof
IL211889A0 (en)	2011-06-30	Pyrazolo pyridine derivatives, compositions comprising the same and uses thereof
SI2217578T1 (en)	2014-03-31	Š1,2,4ćtriazološ1,5-aćpyridine and š1,2,4ćtriazološ1,5-cćpyrimidine compounds and their use
IL201009A0 (en)	2010-05-17	Pyrazolo pyridine derivatives, compositions comprising the same and uses thereof
IL208220A0 (en)	2010-12-30	Substituted imidazoquinolines, compositions comprising the same and uses thereof
EP2160117A4 (en)	2011-08-17	Table construction
GB0701426D0 (en)	2007-03-07	Compounds and their use
IL202616A0 (en)	2010-06-30	Substituted imidazoheterocycles
ZA201001683B (en)	2010-10-27	Substituted piperidino-dihydrothienopyrimidines
GB0803049D0 (en)	2008-03-26	Furniture
IL211891A0 (en)	2011-06-30	Pyrazolo pyridine derivatives, compositions comprising the same and uses thereof
ZA200906812B (en)	2010-12-29	Crig antagonists
IL200780A0 (en)	2010-05-17	Pyridine and pyrimidine derivatives as mglur2 antagonists
IL205666A0 (en)	2010-11-30	Pyridine compounds
EP2111400A4 (en)	2010-07-07	Pyridine compounds and their use as p2y12 antagonists.
IL193882A0 (en)	2009-11-18	Pesticidal composition
IL216581A0 (en)	2012-02-29	Aminopyrazole triazolothiadiazole compounds, compositions comprising the same and uses thereof
GB0809203D0 (en)	2008-06-25	Pesticide composition
IL193880A0 (en)	2009-11-18	Pesticidal composition
ZA200807639B (en)	2009-10-28	Pesticidal composition
PL2240049T3 (en)	2013-03-29	Furniture
GB0716711D0 (en)	2007-10-10	Furniture

Legal Events

Date	Code	Title	Description
2009-09-25	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2009-10-28	17P	Request for examination filed	Effective date: 20090713
2009-10-28	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
2009-10-28	AX	Request for extension of the european patent	Extension state: AL BA MK RS
2010-07-07	A4	Supplementary search report drawn up and despatched	Effective date: 20100607
2010-09-22	17Q	First examination report despatched	Effective date: 20100818
2011-02-04	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2011-03-09	18D	Application deemed to be withdrawn	Effective date: 20100801